Stock LABP LANDOS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Landos Biopharma, Inc.

Equities

LABP

US5150692011

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-04-26 EDT 		5-day change 1st Jan Change
22.31 USD -0.80% Intraday chart for Landos Biopharma, Inc. +2.25% +509.56%
04-02 North American Morning Briefing : Stocks Seen -2- DJ
04-01 HC Wainwright Downgrades Landos Biopharma to Neutral From Buy MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
PR
North American Morning Briefing : Stocks Seen -2-
DJ
HC Wainwright Downgrades Landos Biopharma to Neutral From Buy
MT
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
PR
Deals of the day-Mergers and acquisitions
RE
Sector Update: Health Care Stocks Decline Late Afternoon
MT
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE
PR
Top Midday Gainers
MT
Sector Update: Health Care Stocks Softer in Afternoon Trading
MT
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie
PR
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders
BU
AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump
MT
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie
DJ
AbbVie in Deal to Acquire Landos Biopharma for $137.5 Million
DJ
AbbVie to Acquire Landos Biopharma for About $137.5 Million
MT
AbbVie to Acquire Landos Biopharma for About $137.5 Million
MT
AbbVie to buy Landos to expand pipeline of immunity-related illnesses
RE
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PR
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LABP Stock
  4. News Landos Biopharma, Inc.